Home » Topics » BioWorld Science

BioWorld Science
RSS

Chengdu Fanxi Biopharma discovers thyroid hormone receptor alpha/beta agonists

March 14, 2022

New Bruton tyrosine kinase inhibitors identified at Beijing Innocare Medical Technology

March 14, 2022

TYK2 inhibitors described by Ennovabio (Zhejiang) Pharmaceuticals, Shanghai Ennova Biopharmaceutical

March 14, 2022

Blocking UBE2N evades oncogenic immune signaling in AML

March 14, 2022

Sensei advances preclinical pipeline based on TMAb and ImmunoPhage platforms

March 11, 2022

Poseida Therapeutics reports progress across nonclinical programs

March 11, 2022

Morningside Ventures launches Adiso Therapeutics focused on inflammatory diseases

March 11, 2022

AEterna Zentaris expands research agreement with JMU to support COVID-19 and Chlamydia vaccines

March 11, 2022

Oncternal advances ONCT-808 toward IND filing and ONCT-534 into IND-enabling studies

March 11, 2022

STK-002 enters preclinical toxicology studies for autosomal dominant optic atrophy

March 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...